1AI — Algorae Pharmaceuticals Balance Sheet
0.000.00%
- AU$18.56m
- AU$16.24m
- AU$0.14m
- 44
- 10
- 47
- 24
Annual balance sheet for Algorae Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1.61 | 4.24 | 4.11 | 3.11 | 2.32 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.014 | 0.03 | 0.096 | 0.043 | 0.041 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.63 | 4.27 | 4.21 | 3.19 | 2.4 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.016 | 0.005 | 0.005 | 0 | 0 |
| Long Term Investments | |||||
| Total Assets | 1.64 | 4.27 | 4.21 | 3.19 | 2.4 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.265 | 0.239 | 0.45 | 0.178 | 0.17 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.265 | 0.239 | 0.45 | 0.178 | 0.17 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1.38 | 4.03 | 3.76 | 3.01 | 2.23 |
| Total Liabilities & Shareholders' Equity | 1.64 | 4.27 | 4.21 | 3.19 | 2.4 |
| Total Common Shares Outstanding |